Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P5 is a **pseudogene** referred to as "Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 5" and sometimes as FAM10A5[1][3][4][5][6][8]. This locus represents a processed pseudogene, which means it does not encode a functional protein in humans[4][5]. Although it is predicted to enable protein dimerization activity and may be involved in protein interactions, it has no confirmed protein product or direct molecular function as a therapeutic target[1][5][8][9]. It is located on chromosome 11, and current evidence does not support a therapeutic, biomarker, or receptor role for this pseudogene[4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 5 (ST13P5).